<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(7)</volume><submitter>Ribeiro-Guerra M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Women with a familial predisposition to breast cancer (BC) are offered screening at earlier ages and more frequently than women from the general population.&lt;h4>Methods&lt;/h4>We evaluated the effect of screening mammography in 1552 BC cases with a hereditary predisposition to BC unexplained by &lt;i>BRCA1&lt;/i> or &lt;i>BRCA2&lt;/i> and 1363 unrelated controls. Participants reported their lifetime mammography exposures in a detailed questionnaire. Germline rare deleterious or predicted deleterious variants (D-PDVs) in 113 DNA repair genes were investigated in 82.5% of the women and classified according to the strength of their association with BC. Genes with an odds ratio (OR) &lt; 0.9 was assigned to the Gene Group "Reduced", those with OR ≥ 0.9 and ≤1.1 to Group "Independent", and thos</pubmed_abstract><journal>Cancers</journal><pagination>1062</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11987804</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair Genes.</pubmed_title><pmcid>PMC11987804</pmcid><pubmed_authors>Caron O</pubmed_authors><pubmed_authors>Giraud S</pubmed_authors><pubmed_authors>Cavaciuti E</pubmed_authors><pubmed_authors>Longy M</pubmed_authors><pubmed_authors>Dondon MG</pubmed_authors><pubmed_authors>Lortholary A</pubmed_authors><pubmed_authors>Lesueur F</pubmed_authors><pubmed_authors>Cavaille M</pubmed_authors><pubmed_authors>Beauvallet J</pubmed_authors><pubmed_authors>Fajac A</pubmed_authors><pubmed_authors>Mortemousque I</pubmed_authors><pubmed_authors>Le Gal D</pubmed_authors><pubmed_authors>Lasset C</pubmed_authors><pubmed_authors>Audebert-Bellanger S</pubmed_authors><pubmed_authors>Pujol P</pubmed_authors><pubmed_authors>Venat-Bouvet L</pubmed_authors><pubmed_authors>Mebirouk N</pubmed_authors><pubmed_authors>Lejeune-Dumoulin S</pubmed_authors><pubmed_authors>Soubrier F</pubmed_authors><pubmed_authors>Maugard CM</pubmed_authors><pubmed_authors>Fricker JP</pubmed_authors><pubmed_authors>Bonadona V</pubmed_authors><pubmed_authors>Gladieff L</pubmed_authors><pubmed_authors>Andrieu N</pubmed_authors><pubmed_authors>Dreyfus H</pubmed_authors><pubmed_authors>Fert-Ferrer S</pubmed_authors><pubmed_authors>Ribeiro-Guerra M</pubmed_authors><pubmed_authors>Berthet P</pubmed_authors><pubmed_authors>Luporsi E</pubmed_authors><pubmed_authors>Coupier I</pubmed_authors><pubmed_authors>Tinat J</pubmed_authors><pubmed_authors>Delnatte C</pubmed_authors><pubmed_authors>Gesta P</pubmed_authors><pubmed_authors>Adenis-Lavignasse C</pubmed_authors><pubmed_authors>Belotti M</pubmed_authors><pubmed_authors>Tardivon A</pubmed_authors><pubmed_authors>Chiesa J</pubmed_authors><pubmed_authors>Nambot S</pubmed_authors><pubmed_authors>Nogues C</pubmed_authors><pubmed_authors>Eon-Marchais S</pubmed_authors><pubmed_authors>Stoppa-Lyonnet D</pubmed_authors><pubmed_authors>Buecher B</pubmed_authors><pubmed_authors>Colas C</pubmed_authors><pubmed_authors>Limacher JM</pubmed_authors><pubmed_authors>Gauthier-Villars M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair Genes.</name><description>&lt;h4>Background&lt;/h4>Women with a familial predisposition to breast cancer (BC) are offered screening at earlier ages and more frequently than women from the general population.&lt;h4>Methods&lt;/h4>We evaluated the effect of screening mammography in 1552 BC cases with a hereditary predisposition to BC unexplained by &lt;i>BRCA1&lt;/i> or &lt;i>BRCA2&lt;/i> and 1363 unrelated controls. Participants reported their lifetime mammography exposures in a detailed questionnaire. Germline rare deleterious or predicted deleterious variants (D-PDVs) in 113 DNA repair genes were investigated in 82.5% of the women and classified according to the strength of their association with BC. Genes with an odds ratio (OR) &lt; 0.9 was assigned to the Gene Group "Reduced", those with OR ≥ 0.9 and ≤1.1 to Group "Independent", and thos</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-07-10T03:08:16.367Z</modification><creation>2025-07-10T03:08:16.367Z</creation></dates><accession>S-EPMC11987804</accession><cross_references><pubmed>40227588</pubmed><doi>10.3390/cancers17071062</doi></cross_references></HashMap>